ARS Pharmaceuticals, Inc. Common Stock (SPRY) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for SPRY. 13F holdings as of 2026-06-30.
In 13F filings for the quarter ended June 30, 2026, 198 institutions reported holding SPRY, with 90.4 million shares worth $724.3 million in aggregate.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| RA Capital Management, | 10,860,977 | $87M | UNCHANGED |
| Rubric Capital Management | 8,540,861 | $68M | INCREASED |
| Orbimed Advisors | 8,288,510 | $66M | UNCHANGED |
| Deerfield Management Company, | 7,503,812 | $60M | UNCHANGED |
| BlackRock | 5,311,319 | $43M | INCREASED |
Full institutional holdings, insider history, and congressional trades for ARS Pharmaceuticals, Inc. Common Stock on SentiSense.